Cargando…
Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety
Chronic oral or systemic nonselective nonsteroidal anti-inflammatory drug (NSAID) therapy, ubiquitously used by physicians to treat osteoarthritis-associated pain, is associated with a wide range of symptomatic adverse events, the most frequent and serious of which is gastropathy. Although cardiovas...
Autor principal: | Roth, Sanford H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131982/ https://www.ncbi.nlm.nih.gov/pubmed/21753867 http://dx.doi.org/10.2147/CIA.S21107 |
Ejemplares similares
-
The declining incidence of nonsteroidal anti-inflammatory drug gastropathy in rheumatoid arthritis patients: rates and reasons
por: Fries, J, et al.
Publicado: (2003) -
International Consensus on Guiding Recommendations for Management of Patients with Nonsteroidal Antiinflammatory Drugs Induced Gastropathy-ICON-G
por: Hunt, Richard, et al.
Publicado: (2018) -
Nonsteroidal Anti-Inflammatory Drugs and the Kidney
por: Hörl, Walter H.
Publicado: (2010) -
Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease
por: Schoenberger, Scott D., et al.
Publicado: (2013) -
Nonsteroidal Anti-Inflammatory Drugs and Prostatic Diseases
por: Ishiguro, Hitoshi, et al.
Publicado: (2014)